PROTAGONIST THERAPEU (PTGX) — News & AI sentiment
PROTAGONIST THERAPEU (PTGX) news roundup. 5 stories in the past week, 23 over 30 days. Average 30-day sentiment is 64.5/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 3 sales totalling $34.2M — net selling of $34.2M. US House Periodic Transaction Reports (90-day window): 0 purchases (~$0) and 1 sale (~$33K). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.
PTGX news in the last 24 hours, 7 days, 30 days and 90 days
How much PTGX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.
| Time window | PTGX stories | Avg AI sentiment | Read |
|---|---|---|---|
| Last 24 hours | 0 | — | no coverage |
| Last 7 days | 5 | 68.4/100 | PTGX headlines → |
| Last 30 days | 23 | 64.5/100 | PTGX headlines → |
| Last 90 days | 41 | 60.8/100 | PTGX headlines → |